The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
440
Pacific Institute for Medical Research, Inc.
Los Angeles, California, United States
Reduction of symptomatology associated with Generalized Anxiety Disorder as assessed by the change from baseline to endpoint in the total score of the HAM-A scale.
Assessment of proportion of responders and
patients in remission according to HAM-A scores and CGI ratings by
visit, assessment of the safety and tolerability in patients with GAD
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pharmacology Research Institute
Newport Beach, California, United States
Affiliated Research Institute
San Diego, California, United States
Health Quest Clinical Trials
San Diego, California, United States
Pacific Clinical Research Medical Group
Upland, California, United States
UF Behavioral Health Clinic
Jacksonville, Florida, United States
Janus Center for Psychiatric Research
West Palm Beach, Florida, United States
Atlanta Institute of Medicine & Research - Atlanta Clinic
Atlanta, Georgia, United States
Cunningham Clinical Research, LLC
Edwardsville, Illinois, United States
LSUHSC Anxiety and Mood Disorders Clinic
New Orleans, Louisiana, United States
...and 9 more locations